{"id":"W4303983518","doi":"10.1097/01.hs9.0000890604.66330.a0","title":"P009: Improved Overall Survival with First-Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Dacarbazine; ABVD; Medicine; Hazard ratio; Internal medicine; Vinblastine; Oncology; Population; Progression-free survival; Vincristine; Lymphoma; Confidence interval; Surgery; Chemotherapy; Hodgkin lymphoma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001497611,0.0004100843,0.001163527,0.0001922282,0.0001210569,0.00001964938,0.0001771553,0.00009187454,0.001608691],"category_scores_gemma":[0.00001124752,0.0003025925,0.0001786906,0.001268081,0.00008623344,0.0001412972,0.00008681092,0.0001550578,0.000002184465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000957281,"about_ca_system_score_gemma":0.0004033351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009143157,"about_ca_topic_score_gemma":0.003094113,"domain_scores_codex":[0.9974366,0.0001062128,0.0005367771,0.0007105872,0.0007431417,0.0004667047],"domain_scores_gemma":[0.9984877,0.00007874364,0.0003382156,0.0007198477,0.0001574866,0.0002179892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02555609,0.01753115,0.9301711,0.0001037725,0.00344646,0.0002358717,0.001113016,0.005975927,0.0002628025,0.0001311203,0.0002257536,0.01524694],"study_design_scores_gemma":[0.09646687,0.006871478,0.8810195,0.00007072486,0.001160849,0.000004755289,0.0005707352,0.01054123,0.001250027,0.00000680096,0.001589361,0.0004476233],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977888,0.0001243164,0.00008736236,0.0003382935,0.0000524687,0.001004549,0.0002149655,0.00007191613,0.0003172696],"genre_scores_gemma":[0.9958649,0.00003058733,0.001198797,0.0002554833,0.00002272289,0.0002003057,0.001808539,0.00006979409,0.0005488271],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07091077,"threshold_uncertainty_score":0.9999426,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008250420486286589,"score_gpt":0.2399584770234168,"score_spread":0.2317080565371302,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}